Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for acute intracerebral hemorrhage
ChiCTR1900027065Phase 4Recruiting
- Sponsor
- The Fifth Affiliated Hospital of Zhengzhou University
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tranexamic acid in intracerebral hemorrhage (ICH) (2 arms), sponsored by The Fifth Affiliated Hospital of Zhengzhou University. Primary endpoints: Hematoma volume and Peri-hematomal edema. Started Nov 2019; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on ChiCTR1900027065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900027065.